Multicomponent anthrax toxin display and delivery using bacteriophage T4.
We describe a multicomponent antigen display and delivery system using bacteriophage T4. Two dispensable outer capsid proteins, Hoc (highly antigenic outer capsid protein, 155 copies) and Soc (small outer capsid protein, 810 copies), decorate phage T4 capsid. These proteins bind to the symmetrically localized capsid sites, which appear following prohead assembly and expansion. We hypothesized that multiple antigens fused to Hoc can be displayed on the same capsid and such particles can elicit broad immunological responses. Anthrax toxin proteins, protective antigen (PA), lethal factor (LF), and edema factor (EF), and their functional domains, were fused to Hoc with an N-terminal hexa-histidine tag and the recombinant proteins were over-expressed in E. coli and purified. Using a defined in vitro assembly system, the anthrax-Hoc fusion proteins were efficiently displayed on T4 capsid, either individually or in combinations. All of the 155 Hoc binding sites can be occupied by one antigen, or they can be split among two or more antigens by varying their molar ratio in the binding reaction. Immunization of mice with T4 phage carrying PA, LF, and EF elicited strong antigen-specific antibodies against all antigens as well as lethal toxin neutralization titers. The triple antigen T4 phage elicited stronger PA-specific immune responses than the phage displaying PA alone. These features offer novel avenues to develop customized multicomponent vaccines against anthrax and other pathogenic diseases.
Shivachandra
Sathish B
SB
Department of Biology, 103 McCort Ward Hall, The Catholic University of America, 620 Michigan Ave., NE, Washington, DC 20064, USA.
Li
Qin
Q
Peachman
Kristina K
KK
Matyas
Gary R
GR
Leppla
Stephen H
SH
Alving
Carl R
CR
Rao
Mangala
M
Rao
Venigalla B
VB
D000818:Animals; D022122:Anthrax Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology*; D000942:Antigens, Bacterial / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D001427:Bacterial Toxins / Q000235:genetics / Q000276:immunology*; D017122:Bacteriophage T4 / Q000235:genetics* / Q000276:immunology*; D001665:Binding Sites; D015153:Blotting, Western; D002213:Capsid / Q000276:immunology; D036022:Capsid Proteins / Q000276:immunology; D016503:Drug Delivery Systems; D005260:Female; D018628:Gene Dosage; D051379:Mice; D008808:Mice, Inbred CBA; D019151:Peptide Library; D010957:Plasmids / Q000235:genetics / Q000276:immunology; D011487:Protein Conformation; D017510:Protein Folding; D014614:Vaccines, Synthetic / Q000096:biosynthesis / Q000276:immunology
D022122:Anthrax Vaccines; D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D036022:Capsid Proteins; C108525:HOC protein, T4 phage; D019151:Peptide Library; D014614:Vaccines, Synthetic; C030325:anthrax toxin; C103392:small outer capsid protein, bacteriophage T4